20 February, 2024

PrimeVigilance Bolsters Global Presence through Panacea Acquisition

PrimeVigilance, an Ergomed Group company, is delighted to announce the acquisition of Panacea, a company based in the Isle of Man, British Isles. Since its inception in 2008, Panacea has consistently delivered bespoke pharmacovigilance, regulatory affairs, quality assurance, auditing, and support services to the pharmaceutical, biotech, and medical device sector.


Panacea: The Essential Choice

Panacea’s vision embodies a commitment to being the premier partner of choice for clients seeking tailored pharmacovigilance support services. With an unwavering dedication to building a reputation for excellence and integrity, Panacea stands as the preferred partner for clients and a coveted workplace for industry professionals. Their values of respect, honesty, integrity, and transparency lay the groundwork for exceptional client relationships, fostering true partnerships.


Strategic Alignment with PrimeVigilance

The acquisition of Panacea aligns seamlessly with PrimeVigilance’s broader strategy to expand our Generics, Hybrids, and Biosimilars Portfolio, with a keen focus on the burgeoning Asian market. Panacea’s expertise, established client base, and proven track record in delivering high-quality, tailored PV services for Generics and Biosimilar products position them as an invaluable addition to the PrimeVigilance team.


Shared Values, Shared Success

What elevates this acquisition is the harmonization of culture, service delivery standards, and an unwavering commitment to quality between Panacea and PrimeVigilance. As Panacea integrates into our organization, we anticipate exciting opportunities for shared success, solidifying our standing as a global leader in pharmacovigilance.


Statement from PrimeVigilance President Sally Amanuel

“Welcoming Panacea into the PrimeVigilance organisation is a cause for celebration. Their focus on high-quality bespoke PV services for Generics and Biosimilar products, aligns seamlessly with our market positioning and strategic goals. Panacea’s track record and expertise will play a pivotal role in fortifying our industry position and further aligns with our market ambition of capturing the Asian market.

Panacea’s commitment to excellence, integrity, and client-focused partnerships mirrors our values at PrimeVigilance. Together, we embark on an exciting journey, leveraging the synergies between our organizations to achieve new heights. This acquisition will undoubtedly contribute to PrimeVigilance’s success and our shared commitment to delivering top-tier pharmacovigilance services globally.

With shared culture, service delivery standards, and a dedication to maintaining the highest quality and reputation, the integration of Panacea into PrimeVigilance is a natural fit. We eagerly anticipate the prospects this collaboration brings and the value it adds to our growing portfolio.

We extend a warm welcome to the talented professionals from Panacea joining us on this exciting journey. Together, we are poised to create a positive impact, uphold our commitment to excellence, and further strengthen our position as a global leader in pharmacovigilance.”


Moving Forward Together

At Panacea, their team embodies team spirit, continuous development, and a commitment to excellence. We are confident that Panacea’s pool of talent will play a pivotal role in fuelling PrimeVigilance’s future growth.

We eagerly anticipate the collective achievements that our combined strengths will bring in this exciting new chapter. Thank you for your unwavering support as we continue to strive for excellence in the pharmaceutical industry.



About PrimeVigilance

PrimeVigilance, an Ergomed company, has grown to become the leading Pharmacovigilance specialist company, delivering global solutions for clinical safety and post-marketing pharmacovigilance and medical information from our operational hubs based in Europe, the USA, and Japan.

Our extensive experience enables us to offer a comprehensive, top-quality, cost-effective, and innovative safety solution. Our flexible approach, tailor-made to work with clients, allows us to deliver the services that meet your clinical and post-marketing needs.

PrimeVigilance provides pharmacovigilance solutions to over 200 clients who distribute their products worldwide. PrimeVigilance manages a global Pharmacovigilance system with a choice of leading drug safety databases, stretching to more than 100 countries.

For more information, contact info@primevigilance.com.

Discover how we can help you

This site uses cookies to personalise and customise your experience. By clicking “I Accept", you consent to cookies in accordance with our privacy policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

In order to use this website we use the following technically required cookies
  • __cfduid

Decline all Services
Accept all Services